US FDA authorizes use of chloroquine/hydroxychloroquine for emergency treatment of COVID-19 in hospitalized patientsNational emergency stockpile supply of chloroquine/hydroxychloroquine can be used, but only when participation in clinical trials is not feasible Convalescent plasma: a potential treatment for critically ill patients with COVID-19Early case series results show some promise, but further study required in controlled clinical trials COVID-19: Reasons to discourage off-label drug treatments Randomized controlled trials are the only way to find effective and safe treatments for COVID-19 Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidence Pharmacy and medical organizations issue statements to discourage off-label prescribing No proof that NSAIDs, ACE inhibitors or angiotensin II blockers can worsen the effects of COVID-19 Professional organizations issue statements to counteract misinformation circulating in the media and on social media Aerosol and fomite transmission SARS-CoV-2 is plausible NEJM: presence in aerosol of SARS-CoV-2 similar to that of CoV-1 Helping your patients with diabetes during the coronavirus pandemic People with diabetes, especially those with poor glycemic control, may be at increased risk of more severe symptoms and complications from coronavirus infection Flu vaccine prevented flu in 60% of unvaccinated people: study Vaccination effectiveness was estimated by comparing vaccine coverage of patients who tested negative for influenza versus those who tested positive Hepatitis C antiviral drugs may cause abnormal blood glucose levels Safety review evidence supports a link between direct-acting antivirals and hypoglycemia in patients with diabetes New Canadian guidance on assessing for beta-lactam allergy in children Inaccurate labelling of penicillin allergy in children is associated with negative outcomes First Previous 59 60 61 62 63 Next Last
